News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No significant news articles were published in the past hour to move markets.
  • Global equities traded with little reaction as investors awaited new data or corporate reports.
  • No major central bank statements or policy decisions occurred in the last hour.
  • Energy and commodity prices showed no abrupt moves absent fresh supply or demand news.
  • Bond yields were largely unchanged amid limited new information for rate expectations.
  • Geopolitical and political developments produced no immediate headlines to alter risk sentiment.

Latest Articles

Sodexo Shares Rise After Management Lays Out 'Shift & Grow 2030' Roadmap

Sodexo Shares Rise After Management Lays Out 'Shift & Grow 2030' Roadmap

Sodexo shares climbed after the company presented its 'Shift & Grow 2030' strategic plan at an Investor Day in Paris. The plan sets targets for sustained organic revenue growth and margin expansion by fiscal 2030, backed by defined operating cost and investment envelopes. Management highlighted North America as the primary growth market and preserv…

AeroVironment Shares Climb After Raymond James Raises Rating to Outperform

AeroVironment Shares Climb After Raymond James Raises Rating to Outperform

AeroVironment's stock rose 2% on Thursday after Raymond James upgraded the company from Market Perform to Outperform and set a $210 price target. Analyst Brian Gesuale cited a materially improved risk/reward picture following a 55% decline in the stock since March and a significant reset in forward EBITDA estimates. The firm highlighted early signs…

Nigeria to Publish Poverty and Income Scorecard to Show Reform Benefits

Nigeria to Publish Poverty and Income Scorecard to Show Reform Benefits

Nigeria's finance ministry will produce a public scorecard monitoring reductions in multidimensional poverty, gains in real income per capita, and shifts in inequality, the finance minister said at a Lagos conference. The initiative aims to demonstrate whether economic reforms enacted in 2023 have delivered tangible improvements for households amid…

Geopolitical Tensions Shift Focus to Energy, Nudge TSX Futures Lower

Geopolitical Tensions Shift Focus to Energy, Nudge TSX Futures Lower

Canadian S&P/TSX futures slipped modestly as escalating U.S.-Iran military actions pushed oil prices higher and revived inflation concerns tied to energy. The move undercuts momentum from recent record highs for the Toronto exchange and comes after the Bank of Canada held its policy rate steady, while softer U.S. inflation and labor signals reduce …

E1 Announces Sports.com Predict as Official Prediction Partner

E1 Announces Sports.com Predict as Official Prediction Partner

Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG) announced that its Sports.com Predict platform has been named the Official Prediction Partner for the 2026 UIM E1 World Championship, the first all-electric raceboat racing series. This partnership integrates Sports.com Predict into the E1 fan experience through exclusive prediction mark…

U.S. Bancorp Shares Slip After Strong Q2 Print as Rally Appears Priced In

U.S. Bancorp Shares Slip After Strong Q2 Print as Rally Appears Priced In

U.S. Bancorp shares fell 2.4% in pre-market trading after the bank reported better-than-expected second-quarter results, including adjusted EPS of $1.35 and record revenue of $7.71 billion. The pullback reflected a buy-the-rumor, sell-the-news reaction following weeks of bullish analyst upgrades and a near-52-week high run, while broader market sof…

ABB Shares Dip After Strong Quarter and Record-Size Acquisition Announcement

ABB Shares Dip After Strong Quarter and Record-Size Acquisition Announcement

ABB delivered a robust Q2 with rising revenues, record orders and a double-digit increase in operational EBITA, but shares fell after the company unveiled a $5.5 billion all-cash bid for Rotork. Market caution around the size of the deal, funding decisions and integration execution offset the upbeat earnings beat, leaving the stock lower on subdued…

Quantum Cyber Advances U.S. Production Push After $2.09M in Purchase Orders

Quantum Cyber Advances U.S. Production Push After $2.09M in Purchase Orders

Quantum Cyber N.V. saw its stock climb after disclosing that roughly $2.09 million in purchase orders now sit with its wholly-owned unit, Quantum Drones Corporation, as part of a transaction to acquire a 50,000 square foot manufacturing facility. The move is presented as a step toward direct, U.S.-based production of the company's autonomous defens…

Markets Tepid After Mixed Signals from Chips, Inflation and Geopolitics

Markets Tepid After Mixed Signals from Chips, Inflation and Geopolitics

Global equities and risk assets showed muted responses after uneven corporate results, cooling inflation data and renewed geopolitical tensions. Taiwan Semiconductor Manufacturing Co. delivered a surprise profit jump, but chip shares remained under pressure. Softer U.S. producer price data eased near-term rate-hike bets, yet core PCE remains above …

Twin Vee PowerCats to Merge with USFM; Shares Spike After Deal Announcement

Twin Vee PowerCats to Merge with USFM; Shares Spike After Deal Announcement

Shares of Twin Vee PowerCats Co. (NASDAQ: VEEE) jumped 28% after the company agreed to merge with private USFM Corporation, a U.S.-based mineral exploration firm focused on critical mineral targets in Greenland. The deal calls for a subsidiary of USFM to merge into Twin Vee, while Twin Vee's recreational marine operations will be spun out into a pr…

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

BriaCell Therapeutics has announced the addition of Sunnybrook’s Odette Cancer Centre in Toronto as the first Canadian site for its pivotal Phase 3 clinical trial evaluating Bria-IMT in combination with an immune checkpoint inhibitor for metastatic breast cancer. The expanded trial now includes over 80 active clinical sites across the U.S. and Cana…

ZenaTech Closes 25th Acquisition with Alberta, Canada-based Velocity Geomatics Inc. Expanding Drone as a Service into Environmental and Regulatory Services in the Oil and Gas Sector

ZenaTech Closes 25th Acquisition with Alberta, Canada-based Velocity Geomatics Inc. Expanding Drone as a Service into Environmental and Regulatory Services in the Oil and Gas Sector

ZenaTech, Inc. (Nasdaq: ZENA) has acquired Velocity Geomatics Inc., a Canadian drone-based geomatics company focused on environmental and regulatory compliance services within the oil and gas industry. This marks ZenaTech's 25th acquisition as part of an aggressive expansion of its Drone as a Service (DaaS) platform, extending its presence in a rap…

Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

Medicus Pharma Ltd. has received positive feedback from the FDA and central IRB approval with modifications for its optimized Phase 2 clinical trial of Teverelix®, targeting men with acute urinary retention secondary to benign prostatic hyperplasia. The redesigned study aims to enroll 126 patients, significantly fewer than the previous plan, to eff…

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

Greenwich LifeSciences announced that the European Medicines Agency has approved combining both HLA-A*02 and non-HLA-A*02 breast cancer patients in the randomized arms of their Phase III FLAMINGO-01 trial evaluating GLSI-100 immunotherapy. This follows similar approval from the FDA in the US, effectively doubling enrollment capacity and statistical…

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Plus Therapeutics announces a strategic collaboration with Genomic Testing Cooperative to integrate next-generation sequencing (NGS) technology into its CNSide cerebrospinal fluid assay platform, enhancing DNA and RNA profiling capabilities for CNS cancers. This integration supports Plus' CNS oncology strategy encompassing targeted radiotherapeutic…

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Arbutus Biopharma and its licensee Genevant have initiated multiple international lawsuits against Pfizer and BioNTech to enforce patents protecting their lipid nanoparticle technology used in mRNA COVID-19 vaccines. The company also received approximately $178 million from a settlement with Moderna over patent infringement, including reimbursement…